Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Navarro and Arantxa Valdivia.
David Navarro
Connection Strength
4.985
Arantxa Valdivia
  1. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Eur J Clin Microbiol Infect Dis. 2021 Mar; 40(3):485-494.
    View in: PubMed
    Score: 0.923
  2. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera. J Med Virol. 2021 04; 93(4):2301-2306.
    View in: PubMed
    Score: 0.919
  3. Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR. J Infect. 2021 01; 82(1):e15-e16.
    View in: PubMed
    Score: 0.899
  4. Caveats in interpreting SARS-CoV-2 IgM+ /IgG- antibody profile in asymptomatic health care workers. J Med Virol. 2021 02; 93(2):634-636.
    View in: PubMed
    Score: 0.899
  5. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay. J Med Virol. 2021 02; 93(2):1141-1144.
    View in: PubMed
    Score: 0.895
  6. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021 Mar; 27(3):472.e7-472.e10.
    View in: PubMed
    Score: 0.228
  7. Amplification of human ß-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. J Med Virol. 2021 01; 93(1):48-50.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.